Wagner AG » Molecular Microbiology (Virology)

University of Regensburg

Institute of Medical Microbiology and Hygiene

Molecular Microbiology (Virology)

Universität Regensburg

Prof. Dr. Ralf Wagner

Legal info


 

  • RESEARCH-BACKGROUND
  • RESEARCH-PROJECTS
    • Running Projects
      • RepliVax
      • ForBIMed
      • CUT'HIVAC
      • SynPeptide
      • EHVA
      • EVAC
      • Hector
    • Past Projects
  • PUBLICATIONS
  • LECTURES
  • MEETINGS & EVENTS
  • NEWS & PRESS
  • TEAM
  • JOBS
  • NETWORKING
  • CONTACT
WHO

Running Projects

  • RepliVax: A Novel Replication Competent Flavivirus-based HIV Vaccine Platform, ie RepliVax®, as a Priming Component for Improving Antibody Response

  • ForBIMed: Recombinant Polypeptides with Optimized T-Cell-Activating Properties

  • CUT'HIVAC: Innovative design of HIV vaccines and delivery systems for transcutaneous immunization

  • SynPeptide: Synthetic Biology for the Design and Production of Antibiotic Peptides

  • EHVA: European HIV Vaccine Alliance

  • EVAC: Emerging Viral Vaccine Antigen Insert Consortium

  • Hector: Influence of HIV's glycan shield on the function and longevity of vaccine-induced immune responses